Applications
From the metal ledger to the toolbox.
Because microbes fight so hard for metal, their acquisition systems are exploitable — as drug-delivery routes, as cleanup machinery, as crop nutrition. Here is where microbial metallomics leaves the lab.
Medicine
Turning metal hunger into a weapon.
Trojan-horse antibiotics
Tether a drug to an iron-chelating group, and a bacterium's own iron-piracy machinery ferries the antibiotic across its otherwise impermeable outer membrane. Cefiderocol (Fetroja) — the first siderophore-cephalosporin — was FDA-approved on 14 November 2019, active against carbapenem-resistant Gram-negatives that defeat almost everything else.
Gallium: the iron impostor
Ga³⁺ is nearly identical to Fe³⁺ but cannot be reduced, so it slips into iron pathways and jams them. In a Phase 1 cystic-fibrosis trial, IV gallium disrupted Pseudomonas aeruginosa and improved lung function; a Phase 2 trial reduced bacterial burden though it missed its primary endpoint.
Copper & silver surfaces
The EPA registered antimicrobial copper alloys in 2008 — they kill over 99.9% of MRSA within two hours. In a randomized ICU trial, copper high-touch surfaces cut healthcare-associated infections by roughly 58%. Silver remains a wound-care and device-coating mainstay.
A broad anti-resistance strategy
"Metalloantibiotics," metal complexes, nanoparticles, and metallophore-based delivery are an active frontier against antimicrobial resistance — reviewed in Nature Reviews Chemistry (2023) as a systematic response to a crisis that killed 1.27 million people in 2019 alone.
Environment
Microbes are the planet's metal chemists.
Uranium & chromium cleanup
Metal-reducing bacteria convert soluble, mobile U(VI) into insoluble U(IV), locking uranium in place. In the field at Rifle, Colorado, injecting acetate stimulated native Geobacter and drew down groundwater uranium within weeks. The same logic detoxifies chromium: Cr(VI) → Cr(III).
Biomining & bioleaching
Acid-loving iron- and sulfur-oxidizers like Acidithiobacillus ferrooxidans dissolve copper from ore and pretreat refractory gold at industrial scale — recovering metal without smelting. (Bioleaching supplied ~1.2% of global copper by 2020, down from a historical peak.)
Mercury methylation
A double-edged discovery: two genes, hgcA and hgcB, let microbes convert inorganic mercury into neurotoxic methylmercury that biomagnifies up the food web — the chemistry behind the Minamata disaster. Identifying them gave the first genetic marker to predict where methylmercury forms.
Acid mine drainage
The flip side of biomining: when sulfide minerals meet air and water, the same acidophilic microbes drive a self-sustaining cycle that generates sulfuric acid and mobilizes heavy metals — one of mining's largest environmental problems, and a molecular-geomicrobiology puzzle.
Agriculture & Biotechnology
Feeding crops, and building enzymes.
Microbe-assisted biofortification
Zinc-solubilizing and plant-growth-promoting bacteria secrete organic acids and siderophores that mobilize soil iron and zinc into crops — an eco-friendly complement to breeding. Biofortified crops now reach an estimated 651 million people.
Cleaner food crops
The same rhizosphere microbes can lower toxic-metal uptake: inoculating wheat with Bacillus siamensis cut shoot cadmium by up to 88% in contaminated soil while improving plant growth.
Metalloenzyme biocatalysis
Molybdenum nitrogenase fixes atmospheric nitrogen with the largest metal cluster known; zinc carbonic anhydrase, among the fastest enzymes, is engineered for industrial CO₂ capture. Both are microbial metalloenzymes put to work.
Artificial metalloenzymes
Anchor a synthetic metal catalyst inside a protein scaffold, then evolve it genetically, and you get enzymes for reactions nature never invented — metathesis, transfer hydrogenation — run inside a living cell.
The Stakes
Why this matters, in numbers.
Metallobiology sits underneath three of the century's largest health and environmental challenges. The figures are sourced and current.
A note on honesty
The widely quoted projection of "10 million AMR deaths a year by 2050" is a scenario extrapolation and has been criticized as high; the best measured figure for 2019 is 1.27 million attributable deaths. We cite both, and flag projections as projections.